MYB113 Antibody

What is MYB113 and why are antibodies against it important in plant research?

MYB113 is an R2R3-MYB transcription factor that belongs to the MYB family of transcription factors, which are key regulators of anthocyanin biosynthesis in plants. MYB113 functions as part of the MBW (MYB-bHLH-WD40) protein complex that regulates the expression of anthocyanin-specific biosynthetic genes including dihydroflavonol-4-reductase (DFR), leucoanthocyanidin dioxygenase (LDOX), and UDP-glucose: flavonoid-3-O-glycosyl-transferase (UF3GT) .

Antibodies against MYB113 are crucial tools for studying the molecular mechanisms of anthocyanin regulation, as they enable researchers to:

• Detect and quantify MYB113 protein expression in different tissues

• Investigate protein-protein interactions within the MBW complex

• Identify DNA-binding sites through chromatin immunoprecipitation (ChIP) studies

• Track subcellular localization of MYB113 during development or in response to environmental stimuli

How do MYB113 antibodies differ from antibodies against other MYB transcription factors?

MYB113 shares significant sequence homology with other R2R3-MYB transcription factors involved in anthocyanin biosynthesis, particularly MYB75 (PAP1) and MYB90 (PAP2) in Arabidopsis, and MdMYB1, MdMYBA, and MdMYB10 in apple. These proteins share highly conserved R2R3 domains that bind to DNA but differ in their C-terminal regions .

When generating antibodies against MYB113, researchers must carefully consider:

• Epitope selection to ensure specificity, typically targeting unique regions in the C-terminal domain

• Cross-reactivity testing against closely related MYB proteins, particularly MYB75 and MYB90

• Validation using knockout or overexpression lines to confirm specificity

Unlike antibodies against MYB75, which has been shown to interact with HAT1 primarily through its R2 domain as demonstrated in yeast two-hybrid and BiFC assays , MYB113 antibodies require different validation approaches due to its unique protein interaction profile.

What are the optimal protocols for using MYB113 antibodies in chromatin immunoprecipitation (ChIP) assays?

ChIP assays using MYB113 antibodies require careful optimization to ensure high specificity and yield. Based on protocols used for related MYB transcription factors, a typical ChIP protocol includes:

• Cross-linking protein-DNA complexes with 1% formaldehyde for 10-15 minutes at room temperature

• Quenching with 0.125 M glycine

• Extracting chromatin from plant tissue and fragmenting to 200-500 bp by sonication

• Pre-clearing chromatin with protein A/G beads

• Immunoprecipitating with MYB113 antibody (typically 2-5 μg per reaction) overnight at 4°C

• Washing beads to remove non-specific binding

• Eluting protein-DNA complexes and reversing cross-links

• Purifying DNA for qPCR or sequencing analysis

For optimal results, researchers should:

• Use epitope-tagged MYB113 (e.g., MYB113-MYC) and corresponding tag antibodies when available, as demonstrated in studies with related transcription factors

• Include appropriate controls (IgG, input samples, and when possible, samples from MYB113 knockout plants)

• Validate enrichment by qPCR using primers targeting known MYB-binding regions in anthocyanin biosynthetic gene promoters

How can researchers validate the specificity of commercial MYB113 antibodies?

Validating MYB113 antibody specificity is crucial due to the high homology between MYB family members. A comprehensive validation approach includes:

• Western blot analysis with recombinant MYB113 and related MYB proteins (MYB75, MYB90) to assess cross-reactivity

• Immunoprecipitation followed by mass spectrometry to confirm antibody captures MYB113 specifically

• Immunohistochemistry or immunofluorescence comparing wild-type and myb113 mutant tissues

• Competition assays with purified MYB113 protein to demonstrate specific binding

• Blocking peptide experiments using the immunizing peptide to confirm epitope-specific recognition

For research requiring high specificity, consider generating transgenic plants expressing epitope-tagged MYB113 (e.g., MYB113-HA or MYB113-GFP) and using well-characterized commercial antibodies against these tags, similar to approaches used with MYB75-nYFP and HAT1-cYFP in BiFC assays .

What techniques can be employed to study MYB113 protein-protein interactions using antibodies?

Several antibody-based techniques can elucidate MYB113 interactions with other proteins in the MBW complex:

• Co-immunoprecipitation (Co-IP): This approach can identify native protein complexes containing MYB113. The protocol typically involves:

  • Preparing protein extracts under non-denaturing conditions

  • Immunoprecipitating with MYB113 antibody

  • Analyzing co-precipitated proteins by western blot or mass spectrometry

• Bimolecular Fluorescence Complementation (BiFC): While not directly using antibodies, this complementary technique can validate interactions identified by Co-IP:

  • Generate constructs expressing MYB113 fused to one half of a fluorescent protein (e.g., nYFP)

  • Fuse potential interacting partners to the complementary half (e.g., cYFP)

  • Co-express in plant cells and visualize interaction via fluorescence microscopy

• Proximity Ligation Assay (PLA): This technique uses antibodies to detect proteins in close proximity:

  • Incubate fixed samples with primary antibodies against MYB113 and its potential partner

  • Add secondary antibodies conjugated with oligonucleotides

  • When proteins are in close proximity, oligonucleotides can be ligated and amplified for detection

• ChIP-re-ChIP: To identify genomic regions bound by MYB113 and its interacting partners:

  • Perform first ChIP with MYB113 antibody

  • Elute complexes and perform second ChIP with antibody against interacting partner

  • Analyze by qPCR or sequencing to identify co-occupied regions

How can MYB113 antibodies be used to investigate the dynamics of MBW complex formation during anthocyanin regulation?

The MBW complex, consisting of MYB, bHLH, and WD40 proteins, is central to anthocyanin biosynthesis regulation. MYB113 antibodies can help investigate complex dynamics through:

• Time-course immunoprecipitation studies: Sample tissues at different developmental stages or after environmental treatments (e.g., light, temperature stress) to track changes in MYB113 complex composition.

• Sequential ChIP experiments: Determine if MYB113 and its partners (bHLH factors like TT8/EGL3 and WD40 proteins like TTG1) co-occupy promoters of anthocyanin biosynthetic genes at specific developmental timepoints.

• Quantitative co-immunoprecipitation: Compare the stoichiometry of complex components under different conditions to determine if complex composition changes in response to stimuli.

• Competitive binding assays: Similar to how HAT1 was found to compete with TT8/EGL3 for binding to MYB75 , investigate if other factors compete with components of the MBW complex for binding to MYB113.

For example, research with MYB75 demonstrated that HAT1 physically interacts with MYB75 through the R2 domain and interferes with the formation of the MBW complex . Similar approaches could be applied to study MYB113 regulation using specific antibodies.

What are the challenges in studying histone modifications at MYB113-regulated genes using ChIP-seq approaches?

Investigating histone modifications at MYB113 target genes presents several technical challenges:

• Antibody specificity: Ensure antibodies against histone modifications (e.g., H3ac, H3K4me3) are highly specific, as demonstrated in studies of ethylene's effect on H3ac levels at the PpMYB114 locus .

• Cell type heterogeneity: Anthocyanin accumulation often occurs in specific cell types, so bulk tissue analysis may dilute cell-specific signals. Consider:

  • Fluorescence-activated cell sorting (FACS) to isolate specific cell populations

  • Single-cell ChIP approaches for higher resolution

  • Cell type-specific expression of tagged histones for targeted purification

• Temporal dynamics: Histone modification patterns can change rapidly in response to stimuli. Design experiments with appropriate time points to capture relevant changes.

• Integration with transcriptional data: Correlate histone modification changes with transcriptional responses using RNA-seq or qRT-PCR to establish functional relationships.

• Analysis of multiple modifications: Examine multiple histone marks simultaneously to understand the combinatorial histone code at MYB113 target genes.

The analysis of H3ac levels at the PpMYB114 locus after ethephon and 1-MCP treatment demonstrates how histone acetylation can be regulated by plant hormones to control MYB expression . Similar approaches could be applied to study MYB113 regulation.

How can researchers develop a ChIP-grade antibody specific to MYB113 given its sequence similarity to other MYB proteins?

Developing a highly specific ChIP-grade antibody for MYB113 requires strategic approaches to overcome homology issues:

• Epitope selection strategy:

  • Perform sequence alignment of MYB113 with closely related MYB proteins

  • Identify unique regions, typically in the C-terminal domain

  • Avoid the highly conserved R2R3 DNA-binding domains

  • Select epitopes with good antigenicity and surface exposure

• Antibody development options:

  • Monoclonal antibodies offer higher specificity but may have lower affinity

  • Polyclonal antibodies provide higher sensitivity but require affinity purification

  • Consider developing antibodies against synthetic peptides from unique regions

• Affinity purification approaches:

  • Use immobilized recombinant MYB113 protein for positive selection

  • Apply negative selection with closely related MYB proteins to remove cross-reactive antibodies

• Validation requirements for ChIP applications:

  • Perform western blots with recombinant MYB proteins to assess cross-reactivity

  • Validate by ChIP-qPCR using known MYB binding sites

  • Include appropriate controls (IgG, input samples, and ideally myb113 mutant)

  • Confirm enrichment at expected target genes

What are the most common challenges when performing immunoprecipitation with MYB113 antibodies and how can they be addressed?

Researchers frequently encounter these challenges when using MYB113 antibodies for immunoprecipitation:

When performing Co-IP to detect MYB113 interaction partners, consider:

• Using chemical crosslinking to stabilize transient interactions

• Including appropriate controls (IgG, input samples, and negative control proteins)

• Validating interactions with reciprocal Co-IP experiments

• Confirming specificity with competition experiments using excess purified protein

How can researchers optimize western blot protocols specifically for MYB113 detection?

Western blot optimization for MYB113 detection requires attention to several parameters:

• Sample preparation:

  • Use buffer containing 1% SDS, 10 mM DTT, and protease inhibitors

  • Heat samples at 95°C for 5 minutes to ensure complete denaturation

  • Consider nuclear extraction protocols for enrichment of transcription factors

• Gel electrophoresis:

  • Use 10-12% polyacrylamide gels for optimal resolution of MYB proteins (typically 25-35 kDa)

  • Include positive controls (recombinant MYB113) and negative controls (myb113 mutant tissue)

• Transfer optimization:

  • Use PVDF membranes for higher protein binding capacity

  • Transfer at 100V for 1 hour or 30V overnight at 4°C

  • Verify transfer efficiency with reversible protein stains (Ponceau S)

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk or BSA in TBST

  • Optimize primary antibody dilution (typically 1:1000 to 1:5000)

  • Incubate with primary antibody overnight at 4°C

  • Use high-quality secondary antibodies (typically 1:5000 to 1:10000)

• Signal detection:

  • For low abundance proteins, use enhanced chemiluminescence (ECL) systems

  • Consider fluorescent secondary antibodies for quantitative analysis

  • Optimize exposure times to avoid saturation

• Troubleshooting specific issues:

  • For multiple bands, preabsorb antibody with recombinant related MYB proteins

  • For weak signals, increase protein loading or concentration of primary antibody

  • For high background, increase washing steps or change blocking agent

How can MYB113 antibodies be utilized in single-cell studies of plant development and stress responses?

Single-cell approaches represent a frontier in plant biology, and MYB113 antibodies can be adapted for these applications:

• Single-cell immunohistochemistry:

  • Fix and permeabilize plant tissues with minimal disruption

  • Use fluorophore-conjugated MYB113 antibodies for direct detection

  • Apply tissue clearing techniques for deep imaging

  • Combine with cell type-specific markers for contextual information

• Flow cytometry and FACS applications:

  • Prepare protoplasts from plant tissues

  • Label with fluorescent MYB113 antibodies

  • Sort cells based on MYB113 expression levels

  • Combine with other markers to identify specific cell populations

• Proximity ligation assays at single-cell resolution:

  • Detect MYB113 interactions with partners in specific cell types

  • Visualize protein complexes in their native context

  • Quantify interaction frequency across different cell types

• Integration with single-cell transcriptomics:

  • Sort cells based on MYB113 protein levels

  • Perform single-cell RNA-seq on sorted populations

  • Correlate protein expression with transcriptional profiles

These approaches could provide unprecedented insight into how MYB113 functions in specific cell types during development or in response to environmental stimuli such as light, temperature, or nutrient availability.

What are the considerations for using MYB113 antibodies in studying evolutionary conservation of anthocyanin regulation across plant species?

Using MYB113 antibodies to study evolutionary conservation requires careful consideration of cross-species reactivity:

• Epitope conservation analysis:

  • Align MYB113 sequences from target species

  • Identify conserved regions suitable for antibody recognition

  • Consider generating antibodies against highly conserved epitopes

• Validation across species:

  • Test antibody reactivity with recombinant MYB proteins from different species

  • Perform western blots with protein extracts from multiple species

  • Include appropriate positive and negative controls for each species

• Comparative ChIP studies:

  • Adapt ChIP protocols for different plant tissues and species

  • Identify conserved binding sites through comparative genomics

  • Design primers for qPCR validation based on conserved promoter regions

• Cross-species protein interaction studies:

  • Use MYB113 antibodies to immunoprecipitate complexes from different species

  • Identify conserved and divergent interaction partners

  • Compare complex composition across evolutionary distance

Studies on apple MdMYB1, which shares considerable homology with Arabidopsis MYB transcription factors, demonstrate that MYB functions in anthocyanin regulation are broadly conserved across species . Similar approaches could be applied to study MYB113 conservation using specific antibodies.